Singapore Renal Denervation Market Insights Forecasts to 2033

• The Market is growing at a CAGR of 25.9% from 2023 to 2033
• The Singapore Renal Denervation Market Size is expected to hold a significant share by 2033

The Singapore Renal Denervation Market Size is anticipated to hold a significant share by 2033, growing at a CAGR of 25.9% from 2023 to 2033. The increasing prevalence of hypertension and rising clinical studies are driving the growth of the renal denervation market in Singapore.     

Market Overview

Renal denervation is a minimally invasive procedure used as a novel treatment strategy for patients with uncontrolled blood pressure. The procedure involves the disruption of nerve activity in the renal arteries to lower blood pressure, providing an alternative approach for patients with resistant hypertension. The rise in cases of therapy-resistant hypertension and benefits such as persistent effects, shorter treatment times, and improved safety levels of renal denervation are the main factors driving the demand for renal denervation. The integration of technological advancements including radiofrequency ablation and ultrasound-based systems for enhancing the efficacy and safety of procedures is offering a market opportunity for renal denervation.   

Report Coverage

This research report categorizes the market for the Singapore renal denervation market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Singapore renal denervation market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Singapore renal denervation market.

Driving Factors

Over one in three Singaporeans between the ages of 18 and 74 suffer from hypertension, also known as chronic high blood pressure, according to the National Population Health Survey 2022. This number rose from 35.5% in 2020 to 37.0% in 2022. The rising prevalence of hypertension in the country is responsible for driving the market demand for renal denervation. Further, the rising clinical studies on renal denervation devices such as SYMPLICITY HTN-1 and randomized controlled SYMPLICITY HTN-2 trials are contributing to propelling the market growth.

Restraining Factors

The alternative treatment options for hypertension including medications and lifestyle changes are challenging the renal denervation market. Further, the side effects associated with renal denervation including the emergence of pain are responsible for restraining the market.

Market Segmentation

The Singapore Renal Denervation Market share is classified into product, technology, and end-users.

• The simplicity segment accounted for the largest revenue share of the Singapore renal denervation market in 2023.

The Singapore renal denervation market is segmented by product into simplicity, vessix (V2), enlightn, paradise, iberis, and others. Among these, the simplicity segment accounted for the largest revenue share of the Singapore renal denervation market in 2023. The Symplicity Spyral renal denervation system is an efficient, evidence-based procedural method of treating hypertension that supplements medicine and lifestyle modifications. The increasing cases of chronic diseases including hypertension significantly responsible for driving the market growth.

• The radiofrequency segment dominated the Singapore renal denervation market with the largest market share in 2023.       

Based on the technology, the Singapore renal denervation market is divided into radiofrequency, ultrasound, micro-infusion, and others. Among these, the radiofrequency segment dominated the Singapore renal denervation market with the largest market share in 2023. Radiofrequency ablation is an image-guided technique that uses heat to destroy cells in the renal arteries to reduce nerve activity, thereby decreasing blood pressure. The rapid technological advancement in the product design of catheter-based radiofrequency ablation renal denervation is contributing to driving the market growth.

• The hospital segment is anticipated to dominate the market during the forecast period.

The Singapore renal denervation market is segmented by end-users into hospital, clinics, ambulatory surgery centers, and others. Among these, the hospital segment is anticipated to dominate the market during the forecast period. An interventional cardiologist uses a catheter to deliver ultrasound or radiofrequency (heat) energy to the renal arteries that kill (ablates) the renal nerves to decrease neuronal activity.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Singapore renal denervation market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Laboratories
• Medtronic plc
• Johnson & Johnson
• Boston Scientific Corporation
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In August 2024, The National Heart Centre Singapore (NHCS) and Medtronic signed a memorandum of understanding (MOU) to enhance clinical expertise and medical technologies for cardiac care.

Market Segment

This study forecasts revenue at Singapore, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Singapore Renal Denervation Market based on the below-mentioned segments:

Singapore Renal Denervation Market, By Product

• Simplicity
• Vessix (V2)
• EnligHTN
• Paradise
• Iberis
• Others

Singapore Renal Denervation Market, By Technology

• Radiofrequency
• Ultrasound
• Micro-infusion
• Others

Singapore Renal Denervation Market, By End-users

• Hospital
• Clinics
• Ambulatory Surgery Centers
• Others